Intraocular pharmacokinetics of bevacizumab after a single intravitreal injection in humans. [electronic resource]
Producer: 20081023Description: 508-12 p. digitalISSN:- 1879-1891
- Adult
- Aged
- Aged, 80 and over
- Angiogenesis Inhibitors -- pharmacokinetics
- Antibodies, Monoclonal -- pharmacokinetics
- Antibodies, Monoclonal, Humanized
- Aqueous Humor -- metabolism
- Bevacizumab
- Cataract -- complications
- Cataract Extraction
- Diabetic Retinopathy -- complications
- Enzyme-Linked Immunosorbent Assay
- Female
- Half-Life
- Humans
- Injections
- Macular Degeneration -- complications
- Macular Edema -- etiology
- Male
- Middle Aged
- Prospective Studies
- Retinal Vein Occlusion -- complications
- Vascular Endothelial Growth Factor A -- antagonists & inhibitors
- Vitreous Body
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.